Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine in Advanced, Persistent Or Recurrent Squamous Cell Carcinoma Of The Cervix
NCT00016926Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Apr 2001
- Primary completion
- Jul 2007
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of capecitabine in Cervical Cancer (CC), sponsored by GOG Foundation. Started Apr 2001; status: completed.
02
Drugs
capecitabine
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00016926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00016926.